Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
暂无分享,去创建一个
V. Tombolini | A. Bozzao | V. Tombolini | G. Minniti | M. Valeriani | M. Osti | R. Maurizi Enrici | G. Lanzetta | A. Bozzao | G. Minniti | V. Sanctis | R. Muni | F. Filippone | M. Valeriani | M. F. Osti | U. Paula | G. Lanzetta | R. Maurizi Enrici | F. Filippone | R. Muni | V. Sanctis | U. Paula
[1] K. Hoang-Xuan,et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations , 2004, Cancer.
[2] M. Alfò,et al. Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme , 2006, Anti-cancer drugs.
[3] M. Brada,et al. Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] G. Barnett,et al. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. , 1998, International journal of radiation oncology, biology, physics.
[5] E. Bruera,et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. Mirimanoff,et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] N. Bleehen,et al. A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. , 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).
[8] L. Ackerman,et al. Epidermoid carcinoma of the hand , 1950, Cancer.
[9] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Brian O'Sullivan,et al. Prognostic factors in cancer. , 2003 .
[11] L. Leibovici,et al. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. , 2007, Mayo Clinic proceedings.
[12] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[13] D. Louis,et al. Genetic analyses for predictors of radiation response in glioblastoma. , 2005, International journal of radiation oncology, biology, physics.
[14] M. Chamberlain,et al. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma , 2007, Journal of Neuro-Oncology.
[15] L. Recht,et al. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas , 2003, Cancer.
[16] N. Hagen,et al. Malignant supratentorial glioma in the elderly , 1996, Neurology.
[17] A. Brandes,et al. A prospective study on glioblastoma in the elderly , 2003, Cancer.
[18] J. Cairncross,et al. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. , 1994, International journal of radiation oncology, biology, physics.
[19] P Schaffer,et al. Descriptive epidemiology of cerebral gliomas in France , 1997, Cancer.
[20] A. Gregor,et al. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma , 1994 .
[21] K. Hoang-Xuan,et al. Treatment of Malignant Gliomas in the Elderly , 1999, Journal of Neuro-Oncology.
[22] A. Gregor,et al. Management of patients aged over 60 years with supratentorial glioma: lessons from an audit. , 1991, Surgical neurology.
[23] D. Louis,et al. Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma , 2004, Clinical Cancer Research.
[24] M. Gilbert,et al. Glial neoplasms: classification, treatment, and pathways for the future. , 1996, Oncology nursing forum.
[25] R. Nordal. Prognostic Factors in Cancer, 3rd ed. , 2008 .
[26] R. Aiken. Quality-of-life issues in patients with malignant gliomas. , 1994, Seminars in oncology.
[27] P. Davey,et al. A prospective study of short course radiotherapy in elderly patients with malignant glioma , 1997, Journal of Neuro-Oncology.
[28] D. Nelson,et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.
[29] A. Verma. MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma , 2006 .
[30] A. Martinez,et al. Efficacy of radiotherapy for malignant gliomas in elderly patients. , 1998, International journal of radiation oncology, biology, physics.
[31] S. Preston‐Martin,et al. A population‐based description of glioblastoma multiforme in Los Angeles County, 1974–1999 , 2005, Cancer.
[32] Luc Taillandier,et al. Radiotherapy for glioblastoma in the elderly. , 2007, The New England journal of medicine.